Literature DB >> 28847030

Macrophages in Nonalcoholic Fatty Liver Disease: A Role Model of Pathogenic Immunometabolism.

Oliver Krenkel1, Frank Tacke1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28847030     DOI: 10.1055/s-0037-1604480

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


× No keyword cloud information.
  15 in total

1.  Identification of Key Biomarkers and Immune Infiltration in Liver Tissue after Bariatric Surgery.

Authors:  Xiaoyan Zhang; Jingxin Li; Tiancai Liu; Min Zhao; Baozhu Liang; Hong Chen; Zhen Zhang
Journal:  Dis Markers       Date:  2022-06-25       Impact factor: 3.464

2.  RANKL Is Involved in Runx2-Triggered Hepatic Infiltration of Macrophages in Mice with NAFLD Induced by a High-Fat Diet.

Authors:  Li Zhong; Jianghan Yuan; Lu Huang; Shan Li; Liang Deng
Journal:  Biomed Res Int       Date:  2020-05-25       Impact factor: 3.411

Review 3.  Adaptive immunity: an emerging player in the progression of NAFLD.

Authors:  Salvatore Sutti; Emanuele Albano
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-10-11       Impact factor: 46.802

Review 4.  Adapted Immune Responses of Myeloid-Derived Cells in Fatty Liver Disease.

Authors:  Jana Hundertmark; Oliver Krenkel; Frank Tacke
Journal:  Front Immunol       Date:  2018-10-18       Impact factor: 7.561

5.  The enigma of soluble LDLR: could inflammation be the key?

Authors:  Majambu Mbikay; Janice Mayne; Michel Chrétien
Journal:  Lipids Health Dis       Date:  2020-02-03       Impact factor: 3.876

Review 6.  Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases.

Authors:  Daphne van der Heide; Ralf Weiskirchen; Ruchi Bansal
Journal:  Front Immunol       Date:  2019-12-03       Impact factor: 7.561

Review 7.  Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis.

Authors:  Rasmus Hvidbjerg Gantzel; Mikkel Breinholt Kjær; Tea Lund Laursen; Konstantin Kazankov; Jacob George; Holger Jon Møller; Henning Grønbæk
Journal:  Front Med (Lausanne)       Date:  2021-01-08

Review 8.  Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention.

Authors:  Frank Tacke; Ralf Weiskirchen
Journal:  Ann Transl Med       Date:  2021-04

Review 9.  Crosstalk Between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis.

Authors:  Haiou Li; Yunjiao Zhou; Haizhou Wang; Meng Zhang; Peishan Qiu; Mengna Zhang; Ruike Zhang; Qiu Zhao; Jing Liu
Journal:  Front Immunol       Date:  2020-06-24       Impact factor: 7.561

Review 10.  Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism.

Authors:  Sander Lefere; Frank Tacke
Journal:  JHEP Rep       Date:  2019-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.